Dementia
Review
The New Era of Alzheimer Disease Therapy — A 2026 Neurologist's Guide
For two decades, Alzheimer therapy meant cholinesterase inhibitors and memantine. Two FDA-approved anti-amyloid antibodies — lecanemab and donanemab — now slow cognitive decline by 27–35% over 18 months, and brexpiprazole…
